(Reuters Health) - Information about the benefits and drawbacks patients experienced when taking a new cancer drug is rarely included on the product label, even though it could help doctors and patients make treatment choices, researchers say.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire